Luliclinz Spray contains Luliconazole 1% w/v, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and cell death. This formulation is primarily used for conditions such as tinea corporis, tinea cruris, and tinea pedis. Luliclinz Spray offers a convenient and non-greasy application, promoting patient compliance. It is typically applied once daily to the affected area and surrounding skin after cleansing and drying, continuing treatment for the prescribed duration to ensure complete eradication of the infection. Adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Luliclinz Spray is contraindicated in patients with known hypersensitivity to luliconazole or any excipients. Caution is advised in pregnant or breastfeeding women due to limited safety data. As with all antifungal treatments, adherence to the full course of therapy is essential to prevent recurrence and resistance. Consult a healthcare professional before use for appropriate diagnosis and treatment guidance.